AbbVie Inc. ABBV

264.34 (0.78) (0.29%) as of 25 Sep
Market cap
$467.4B
P/E
74.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

AbbVie Inc. (ABBV) Current ratio

AbbVie Inc.'s current ratio at the end of the quarter to 30 June 2026 was 0.8×, up 0.1× from fiscal 2025 (0.7×). Over the past ten years it has ranged from 0.7× (fiscal 2024) to 3.2× (fiscal 2019); the current reading is higher than 18% of that period. That is below the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Annual

Period Current ratio Change
FY2025 0.7× 1.68%
FY2024 0.7× (24.30%)
FY2023 0.9× (9.50%)
FY2022 1.0× 21.44%
FY2021 0.8× (5.92%)
FY2020 0.8× (73.46%)
FY2019 3.2× 223.27%
FY2018 1.0× (22.93%)
FY2017 1.3× (22.94%)
FY2016 1.7× 10.51%

Quarterly

Period Current ratio Change
Jun 2026 0.8× 1.52%
Mar 2026 0.8× 18.64%
Dec 2025 0.7× (7.34%)
Sep 2025 0.7× (1.54%)
42 more quarters

Against its own ten years

Low 0.7× High 3.2×
Ten-year median 1.0×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
AMGN Amgen Inc. compare 1.4×
LLY Eli Lilly and Company compare 1.4×
MRK Merck & Co., Inc. compare 1.3×
PFE Pfizer Inc. compare 1.3×
GILD Gilead Sciences, Inc. compare 1.3×
JNJ Johnson & Johnson compare 1.1×
AZN AstraZeneca PLC compare 0.9×
NVS Novartis AG compare 0.9×
ABBV AbbVie Inc. 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on ABBV